...hopes to have results about a year after the trial starts. Davidson was CMO of Omthera Pharmaceuticals Inc....

...Ligand partnered with AstraZeneca's Omthera Pharmaceuticals Inc. subsidiary to develop products to treat dyslipidemia, including hypertriglyceridemia. The products...
...for milestone payments of up to $44.5 million, as well as tiered, mid-to-high, single-digit royalties. Omthera...
...molecule into an inactive prodrug to be activated by enzymes in the liver. AZ acquired Omthera...

...guidance in last week's review. AZ gained the product in its July 2013 acquisition of Omthera Pharmaceuticals Inc....

...AZ gained the product through its July acquisition of Omthera Pharmaceuticals Inc. (see BioCentury, July 22, 2013). Omthera...

...has not yet set a price. AZ gained Epanova through its acquisition last year of Omthera Pharmaceuticals Inc....

...Radnor, Pa. Business: Infectious Hired: Christian Schade as CEO, formerly EVP and CFO of Omthera Pharmaceuticals Inc....

...DHA). AstraZeneca gained the product through its July acquisition of Omthera Pharmaceuticals Inc. (see BioCentury, July 22). Omthera...

...acid (EPA) and docosahexaenoic acid (DHA). AstraZeneca gained the product through its July acquisition of Omthera Pharmaceuticals Inc....

...NASDAQ:PETX) 6/27/13 $39.7 62% 13% 49% Portola Pharmaceuticals Inc. (NASDAQ:PTLA) 5/22/13 $140.4 60% 11% 49% Omthera Pharmaceuticals Inc....

...the pharma's third significant deal in as many months, following the acquisitions of hypertriglyceridemia company Omthera Pharmaceuticals Inc....